3
|
Als TD, Kurki MI, Grove J, Voloudakis G, Therrien K, Tasanko E, Nielsen TT, Naamanka J, Veerapen K, Levey DF, Bendl J, Bybjerg-Grauholm J, Zeng B, Demontis D, Rosengren A, Athanasiadis G, Bækved-Hansen M, Qvist P, Bragi Walters G, Thorgeirsson T, Stefánsson H, Musliner KL, Rajagopal VM, Farajzadeh L, Thirstrup J, Vilhjálmsson BJ, McGrath JJ, Mattheisen M, Meier S, Agerbo E, Stefánsson K, Nordentoft M, Werge T, Hougaard DM, Mortensen PB, Stein MB, Gelernter J, Hovatta I, Roussos P, Daly MJ, Mors O, Palotie A, Børglum AD. Depression pathophysiology, risk prediction of recurrence and comorbid psychiatric disorders using genome-wide analyses. Nat Med 2023; 29:1832-1844. [PMID: 37464041 PMCID: PMC10839245 DOI: 10.1038/s41591-023-02352-1] [Citation(s) in RCA: 60] [Impact Index Per Article: 60.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Accepted: 04/17/2023] [Indexed: 07/20/2023]
Abstract
Depression is a common psychiatric disorder and a leading cause of disability worldwide. Here we conducted a genome-wide association study meta-analysis of six datasets, including >1.3 million individuals (371,184 with depression) and identified 243 risk loci. Overall, 64 loci were new, including genes encoding glutamate and GABA receptors, which are targets for antidepressant drugs. Intersection with functional genomics data prioritized likely causal genes and revealed new enrichment of prenatal GABAergic neurons, astrocytes and oligodendrocyte lineages. We found depression to be highly polygenic, with ~11,700 variants explaining 90% of the single-nucleotide polymorphism heritability, estimating that >95% of risk variants for other psychiatric disorders (anxiety, schizophrenia, bipolar disorder and attention deficit hyperactivity disorder) were influencing depression risk when both concordant and discordant variants were considered, and nearly all depression risk variants influenced educational attainment. Additionally, depression genetic risk was associated with impaired complex cognition domains. We dissected the genetic and clinical heterogeneity, revealing distinct polygenic architectures across subgroups of depression and demonstrating significantly increased absolute risks for recurrence and psychiatric comorbidity among cases of depression with the highest polygenic burden, with considerable sex differences. The risks were up to 5- and 32-fold higher than cases with the lowest polygenic burden and the background population, respectively. These results deepen the understanding of the biology underlying depression, its disease progression and inform precision medicine approaches to treatment.
Collapse
Affiliation(s)
- Thomas D Als
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
- Center for Genomics and Personalized Medicine, Aarhus, Denmark.
| | - Mitja I Kurki
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
| | - Jakob Grove
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, Aarhus, Denmark
- Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark
| | - Georgios Voloudakis
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Mental Illness Research, Education, and Clinical Center (VISN 2 South), James J Peters VA Medical Center, Bronx, NY, USA
| | - Karen Therrien
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Mental Illness Research, Education, and Clinical Center (VISN 2 South), James J Peters VA Medical Center, Bronx, NY, USA
- Nash Family Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Elisa Tasanko
- Department of Psychology and Logopedics, SleepWell Research Program, University of Helsinki, Helsinki, Finland
| | - Trine Tollerup Nielsen
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, Aarhus, Denmark
| | - Joonas Naamanka
- Department of Psychology and Logopedics, SleepWell Research Program, University of Helsinki, Helsinki, Finland
| | - Kumar Veerapen
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Department of Medicine, Harvard Medical School, Boston, MA, USA
| | - Daniel F Levey
- Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
- Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA
| | - Jaroslav Bendl
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Jonas Bybjerg-Grauholm
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
| | - Biao Zeng
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Ditte Demontis
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, Aarhus, Denmark
| | - Anders Rosengren
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Mental Health Centre Sct. Hans, Capital Region of Denmark, Institute of Biological Psychiatry, Copenhagen University Hospital, Copenhagen, Denmark
| | - Georgios Athanasiadis
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Mental Health Centre Sct. Hans, Capital Region of Denmark, Institute of Biological Psychiatry, Copenhagen University Hospital, Copenhagen, Denmark
- Department of Evolutionary Biology, Ecology and Environmental Sciences, University of Barcelona, Barcelona, Spain
| | - Marie Bækved-Hansen
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
| | - Per Qvist
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, Aarhus, Denmark
| | | | | | | | - Katherine L Musliner
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- National Centre for Register-Based Research (NCRR), Business and Social Sciences, Aarhus University, Aarhus, Denmark
- Department of Affective Disorders, Aarhus University Hospital-Psychiatry, Aarhus, Denmark
- The Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
| | - Veera M Rajagopal
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, Aarhus, Denmark
| | - Leila Farajzadeh
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, Aarhus, Denmark
| | - Janne Thirstrup
- Department of Biomedicine, Aarhus University, Aarhus, Denmark
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Genomics and Personalized Medicine, Aarhus, Denmark
| | - Bjarni J Vilhjálmsson
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark
- National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark
| | - John J McGrath
- National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark
- Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Brisbane, Queensland, Australia
- Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia
| | - Manuel Mattheisen
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Institute of Psychiatric Phenomics and Genomics (IPPG), University Hospital, LMU Munich, Munich, Germany
- Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada
- Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada
| | - Sandra Meier
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada
- Faculty of Computer Science, Dalhousie University, Halifax, Nova Scotia, Canada
- Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada
| | - Esben Agerbo
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- National Centre for Register-Based Research (NCRR), Business and Social Sciences, Aarhus University, Aarhus, Denmark
- Centre for Integrated Register-based Research, CIRRAU, Aarhus University, Aarhus, Denmark
| | | | - Merete Nordentoft
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Mental Health Centre Copenhagen, Capital Region of Denmark, Copenhagen University Hospital, Copenhagen, Denmark
| | - Thomas Werge
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Mental Health Centre Sct. Hans, Capital Region of Denmark, Institute of Biological Psychiatry, Copenhagen University Hospital, Copenhagen, Denmark
- Institute of Clinical Sciences and GLOBE Institute, LF Center for GeoGenetics, University of Copenhagen, Copenhagen, Denmark
| | - David M Hougaard
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark
| | - Preben B Mortensen
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- National Centre for Register-Based Research (NCRR), Business and Social Sciences, Aarhus University, Aarhus, Denmark
- Centre for Integrated Register-based Research, CIRRAU, Aarhus University, Aarhus, Denmark
| | - Murray B Stein
- Psychiatry Service, VA San Diego Healthcare System, San Diego, CA, USA
- Departments of Psychiatry and Herbert Wertheim School of Public Health, University of California, San Diego, La Jolla, CA, USA
| | - Joel Gelernter
- Division of Human Genetics, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA
- Department of Psychiatry, Veterans Affairs Connecticut Healthcare Center, West Haven, CT, USA
| | - Iiris Hovatta
- Department of Psychology and Logopedics, SleepWell Research Program, University of Helsinki, Helsinki, Finland
| | - Panos Roussos
- Center for Disease Neurogenomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Mental Illness Research, Education, and Clinical Center (VISN 2 South), James J Peters VA Medical Center, Bronx, NY, USA
- Center for Dementia Research, Nathan Kline Institute for Psychiatric Research, Orangeburg, NY, USA
| | - Mark J Daly
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA
- Department of Medicine, Harvard Medical School, Boston, MA, USA
| | - Ole Mors
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark
- Psychosis Research Unit, Aarhus University Hospital-Psychiatry, Aarhus, Denmark
| | - Aarno Palotie
- Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland
| | - Anders D Børglum
- Department of Biomedicine, Aarhus University, Aarhus, Denmark.
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Aarhus, Denmark.
- Center for Genomics and Personalized Medicine, Aarhus, Denmark.
| |
Collapse
|
32
|
Bruffaerts R, Posada-Villa J, Al-Hamzawi AO, Gureje O, Huang Y, Hu C, Bromet EJ, Viana MC, Hinkov HR, Karam EG, Borges G, Florescu SE, Williams DR, Demyttenaere K, Kovess-Masfety V, Matschinger H, Levinson D, de Girolamo G, Ono Y, de Graaf R, Browne MO, Bunting B, Xavier M, Haro JM, Kessler RC. Proportion of patients without mental disorders being treated in mental health services worldwide. Br J Psychiatry 2015; 206:101-9. [PMID: 25395690 PMCID: PMC4312965 DOI: 10.1192/bjp.bp.113.141424] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/19/2013] [Revised: 04/15/2014] [Accepted: 06/27/2014] [Indexed: 11/23/2022]
Abstract
BACKGROUND Previous research suggests that many people receiving mental health treatment do not meet criteria for a mental disorder but are rather 'the worried well'. AIMS To examine the association of past-year mental health treatment with DSM-IV disorders. METHOD The World Health Organization's World Mental Health (WMH) Surveys interviewed community samples of adults in 23 countries (n = 62 305) about DSM-IV disorders and treatment in the past 12 months for problems with emotions, alcohol or drugs. RESULTS Roughly half (52%) of people who received treatment met criteria for a past-year DSM-IV disorder, an additional 18% for a lifetime disorder and an additional 13% for other indicators of need (multiple subthreshold disorders, recent stressors or suicidal behaviours). Dose-response associations were found between number of indicators of need and treatment. CONCLUSIONS The vast majority of treatment in the WMH countries goes to patients with mental disorders or other problems expected to benefit from treatment.
Collapse
Affiliation(s)
- Ronny Bruffaerts
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Jose Posada-Villa
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Ali Obaid Al-Hamzawi
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Oye Gureje
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Yueqin Huang
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Chiyi Hu
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Evelyn J Bromet
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Maria Carmen Viana
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Hristo Ruskov Hinkov
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Elie G Karam
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Guilherme Borges
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Silvia E Florescu
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - David R Williams
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Koen Demyttenaere
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Viviane Kovess-Masfety
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Herbert Matschinger
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Daphna Levinson
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Giovanni de Girolamo
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Yutaka Ono
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Ron de Graaf
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Mark Oakley Browne
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Brendan Bunting
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Miguel Xavier
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Josep Maria Haro
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| | - Ronald C Kessler
- Ronny Bruffaerts, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Jose Posada-Villa, MD, Colegio Mayor de Cundinamarca University, Bogota, Colombia; Ali Obaid Al-Hamzawi, DM, FICMSAl-Qadisia University College of Medicine, Diwania, Iraq; Oye Gureje, MD, PhD, DSc, FRCPsych, WHO Collaborating Centre for Research and Training in Mental Health, Neurosciences, and Drug & Alcohol Abuse, Department of Psychiatry, University College Hospital, Ibadan, Nigeria; Yueqin Huang, MD, MPH, PhD, Institute of Mental Health, Key Laboratory of Ministry of Health, Peking University, Haidian, Beijing, China; Chiyi Hu, MD, PhD, Shenzhen Institute of Mental Health and Shenzhen Kangning Hospital, Guangdong Province, PR China; Evelyn J. Bromet, PhD, State University of New York at Stony Brook, Department of Psychiatry, New York, USA; Maria Carmen Viana, MD, PhD, Department of Social Medicine, Federal University of Espírito Santo (UFES), Vitória, Espírito Santo, Brazil; Hristo Ruskov Hinkov, MD, PhD, National Center for Public Health and Analyses, Sofia, Bulgaria; Elie G. Karam, MD, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Medical Institute for Neuropsychological Disorders (MIND), Beirut, Lebanon; Guilherme Borges, MSc, DrSc, Division of Epidemiological and Psychosocial Research, National Institute of Psychiatry (Mexico) & Metropolitan Autonomous University, Mexico City, Mexico; Silvia E. Florescu, MD, PhD, National School of Public Health, Management and Professional Development, 31 Vaselor Street, Bucharest, Romania; David R. Williams, MPH, PhD, Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, USA; Koen Demyttenaere, MD, PhD, Universitair Psychiatrisch Centrum - KULeuven (UPC-KUL), Leuven, Belgium; Viviane Kovess-Masfety, MD, PhD, EA 4069 Université Paris Descartes & EHESP School for Public Health Depa
| |
Collapse
|